Lakefront Biotherapeutics NV LKFT
Set alert
32.28 USD -0.05 -0.15%
At close · Oct 30
32.28 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
32.06 Day range 32.76
26.08 52-week range 34.64
- YTD
- -1.28%
- 1 year
- +3.00%
- Open
- 32.42
- Prev close
- 32.33
- Mkt cap
- 2.13B
- Vol
- 164.06K
- Avg vol
- 285.76K
- EPS
- 10.52
- P/E
- 3.07
- Div yield
- 0.00%
More statistics
- Low
- 32.06
- High
- 32.76
- Forward P/E
- -27.11
- Beta
- 0.06
- Short ratio
- 3.95
- Inst. own
- 23.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 29.41
- 200-d avg
- 29.93
- 1y target
- 30.34
2Y chart
Events in this range
- Jul 23, 2025Earnings: -1.85303; estimate -0.22826; surprise -711.81%
- Nov 5, 2025Earnings: -3.54263; estimate -0.47781; surprise -641.43%
- Feb 23, 2026Earnings: 13.9; estimate -0.12662; surprise 11077.73%
- Feb 25, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- May 6, 2026Earnings: 0.2473; estimate -0.94363; surprise 126.21%
- Aug 10, 2026Earnings: 0.03448; estimate -0.82265; surprise 104.19%
- Aug 11, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Aug 11, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Sep 23, 2026Rating: RBC Capital · Sector Perform → Outperform
Signals (76)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| RSI: Oversold | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 16, 2026 | 4 months ago |
| SMA: Bullish | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 15, 2026 | 6 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 30, 2026 | 9 months ago |
| SMA: Bullish | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 18, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Oct 21, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| RSI: Overbought | Oct 3, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 12, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 6, 2025 | 1 year ago |
| RSI: Overbought | Jul 18, 2025 | 1 year ago |
| RSI: Overbought | Jul 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 3, 2025 | 1 year ago |
| SMA: Bullish | Jun 24, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 4, 2025 | 1 year ago |
| RSI: Overbought | May 28, 2025 | 1 year ago |
| RSI: Overbought | May 20, 2025 | 1 year ago |
| MACD: Buy Signal | May 15, 2025 | 1 year ago |
| SMA: Bullish | May 13, 2025 | 1 year ago |
| SMA: Bearish | May 8, 2025 | 1 year ago |
| MACD: Sell Signal | May 8, 2025 | 1 year ago |
| RSI: Overbought | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| RSI: Overbought | Feb 18, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 7, 2025 | 1 year ago |
| RSI: Oversold | Jan 23, 2025 | 1 year ago |
| RSI: Oversold | Jan 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 24, 2024 | 1 year ago |
Key statistics
- Market cap
- 2.13B
- Enterprise value
- 40.22B
- Trailing P/E
- 3.07
- Forward P/E
- -27.11
- PEG ratio
- 0.00
- Price / sales
- 2.15
- Price / book
- 11.56
- EPS (TTM)
- 10.52
- Beta
- 0.06
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 60.23%
- Revenue (TTM)
- 990.57M
- Revenue growth
- -81.50%
- Free cash flow
- 138.21M
- Total cash
- 2.24B
- Total debt
- 6.36M
- Return on equity
- 20.12%
- Shares outstanding
- 65.90M
- Short % of float
- 3.50%
- 50-day average
- 29.41
- 200-day average
- 29.93
Analyst view
Consensus: hold
Hold
Price target (mean) 30.34 -6.0% downside
Now 32.28
- Target (low)
- 21.22
- Target (mean)
- 30.34
- Target (high)
- 43.92
Ratings (0m) 6 2 buy · 3 hold · 1 sell
- Strong buy1
- Buy1
- Hold3
- Sell1
- Strong sell0
Next earnings
Nov 11, 2026
Expected Nov 11, 2026. Consensus EPS estimate 0.23.
Financials — quick view
LKFT Revenue — quarterly 8.06M
LKFT Net income — quarterly 14.49M
LKFT EPS — quarterly 0.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2026 | Sep 30, 2026 | -0.83178 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | -0.82265 | 0.03448 | +0.86 | +104.19% |
| May 6, 2026 | Mar 31, 2026 | -0.94363 | 0.2473 | +1.19 | +126.21% |
| Feb 23, 2026 | Dec 31, 2025 | -0.12662 | 13.90 | +14.03 | +11,077.73% |
| Nov 5, 2025 | Sep 30, 2025 | -0.47781 | -3.54 | -3.06 | -641.43% |
| Jul 23, 2025 | Jun 30, 2025 | -0.22826 | -1.85 | -1.62 | -711.81% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | RBC Capital | up | Sector Perform | Outperform |
| Aug 11, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Aug 11, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Feb 25, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
About Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Belgium
- Website
- lakefrontbio.com
News
- Oncocyte (NASDAQ:IMDX) and Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Head-To-Head Analysis
- Lakefront Biotherapeutics - Sponsored ADR (LKFT) Upgraded to Buy: What Does It Mean for the Stock?
- Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
- Acquisition of Own Shares
- Bank Of America Crosses Below Threshold Of 10% Of Lakefront's Voting Rights, Transparency Notification Shows
- Acquisition of Own Shares
- Acquisition of Own Shares
- This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
- Crude Oil Gains 1%; Cintas Earnings Top Views
- TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
Your note
Sign in to keep a note on LKFT — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gilead Sciences Inc | 25.35% | 16,707,477 | 539.32M | Jun 29, 2026 |
| Tang Capital Management, LLC | 5.75% | 3,785,991 | 122.21M | Jun 29, 2026 |
| Madison Avenue Partners, LP | 5.23% | 3,447,807 | 111.30M | Jun 29, 2026 |
| Prosight Management, Lp | 3.10% | 2,043,344 | 65.96M | Jun 29, 2026 |
| EcoR1 Capital, LLC | 2.53% | 1,667,119 | 53.81M | Jun 29, 2026 |
| Ameriprise Financial, Inc. | 1.93% | 1,272,249 | 41.07M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Columbia Funds Series Trust-Columbia Overseas Value Fund | 0.90% | 595,589 | 19.23M | Aug 30, 2026 |
| Columbia Fd.s Varbl Series TRT II-Columbia Varbl PORT. - Overseas Core | 0.43% | 280,317 | 9.05M | Jun 29, 2026 |
| ALPS ETF TRUST-ALPS Medical Breakthroughs ETF | 0.12% | 80,031 | 2.58M | Aug 30, 2026 |
| American Century ETF Trust-Avantis International Equity ETF | 0.05% | 30,449 | 982.89K | Sep 29, 2026 |
| Steward Funds Inc-Steward Values Enhanced International Fund | 0.03% | 16,569 | 534.85K | Jul 30, 2026 |
| Trust for Professional Managers-ActivePassive International Equity ETF | 0.03% | 19,649 | 634.27K | Aug 30, 2026 |